Photo

Photo detail

Stories this photo appears in:

FDA Declines to Approve Allergan’s Levadex

The Food and Drug Administration cited manufacturing concerns in rejecting Irvine-based Allergan Inc.’s request for approval to market Levadex, a drug to treat acute migraine headaches.

Tease photo